Silencing HIF-1 alpha aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-alpha/ANGPTL4 singling pathway

He, Y; Yang, WH; Gan, LL; Liu, SJ; Ni, Q; Bi, YX; Han, T; Liu, Q; Chen, HY; Hu, Y; Long, Y; Yang, L

Yang, L (corresponding author), Kunming Med Univ, Yanan Hosp,Key Lab Canc Immunodeficiency Yunnan P, Yunnan Cardiovasc Hosp,Elderly Cardiovasc Dis Tec, Key Lab Cardiovasc Dis Yunnan Prov,Heart Dis Clin, Kunming, Yunnan, Peoples R China.

GASTROENTEROLOGIA Y HEPATOLOGIA, 2021; 44 (5): 355

Abstract

Objective: Non-alcoholic fatty liver disease (NAFLD) is an aberrant lipid metabolism disease. Hypoxia inducible factor-1 (HIF-1 alpha) is a transcript......

Full Text Link